Egyptian Drug Exports To Iraqi

17 February 1997

The first batch of Egyptian exports of medicines to Iraq is due to bedelivered this month, in line with a $3 million contract signed between the two countries in Cairo in January.

The Iraqi pharmaceutical authority had urged the Egyptian National Pharmaceutical Company to deliver the medicines speedily because of the Iraqi people's urgent need, the Egyptian Middle East News Agency reports. The company will receive payment directly from the United Nations Sanctions Committee in charge of paying war reparations and covering the costs of all Iraqi purchases of food and medicines.

.....But Not From Turkey So far, 29 countries and districts have offered to sell food and medicine to Iraq, which has suffered a six-year international embargo. However, press reports in the Turkish capital of Ankara say that out of 60 applications by Turkish firms to export pharmaceuticals to Iraq, the Iraqi government has approved only six, notes the Turkish EBA Newsletter.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight